Fight for coveted CRISPR patents gets knottier, as a new party weighs in

After nearly seven years of failing to win fundamental patents on the genome-editing technology CRISPR, a unit of one of the world’s largest life sciences companies has thrown a Hail Mary: Late last Friday, MilliporeSigma petitioned the U.S. Patent and Trademark office to open an interference proceeding between CRISPR-Cas9 patents that it applied for way back in 2012 and patents that the University of California has applied for or been awarded.

Source: Fight for coveted CRISPR patents gets knottier, as a new party weighs in